
Gene Quinn
Articles
-
1 week ago |
ipwatchdog.com | Eileen McDermott |Gene Quinn |Steve Brachmann |Stephen Schreiner
“PERA 2025 still says that unmodified human genes as they exist in the human body are not patent eligible, but prior versions of the bill said that isolation of genes was considered a modification.”Senators Marsha Blackburn (R-TN) and Mazie Hirono (D-HI) today signed onto the Patent Eligibility Restoration Act of 2025 as co-sponsors with Senators Thom Tillis (R-NC) and Chris Coons (D-DE).
-
1 week ago |
ipwatchdog.com | Eileen McDermott |Gene Quinn |Steve Brachmann |Stephen Schreiner
“The petition argued that ‘[p]atents would provide little protection if confined to the strict, literal terms of their claims; ‘[o]utright and forthright duplication is a dull and very rare type of infringement,’ and ‘[t]o prohibit no other would place the inventor at the mercy of verbalism.’” The U.S. Supreme Court on Monday declined to grant a number of IP petitions, including one in which a divided panel of the U.S. Court of Appeals for the Federal Circuit (CAFC) ruled in October 2024 that...
-
1 week ago |
ipwatchdog.com | Steve Brachmann |Gene Quinn
“Siding with Apple, the Federal Circuit ruled that the district court’s verdict form violated Apple’s right under the Seventh Amendment to a jury trial on each legal claim against it presented by Optis.”Today, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential ruling in Optis Cellular Technology, LLC v. Apple, Inc. vacating infringement and damages judgments awarded to Optis by the Eastern District of Texas.
-
1 week ago |
ipwatchdog.com | Eileen McDermott |Gene Quinn
“The large number and vast scope of the patents asserted in the district court litigation… weighs against discretionary denial, as the Board is better suited to review a large number of patents involving diverse subject matter.” – Director Discretionary Denial Decision in IPR2025-00341 Following the release of 11 Director Review decisions on discretionary denial on Thursday, June 12, Acting Director Coke Morgan Stewart issued two additional decisions late Friday, both of which denied the...
-
1 week ago |
ipwatchdog.com | Stephen Schreiner |Gene Quinn |Steve Brachmann
“In finding that the petitioner’s prior knowledge of the patent and its failure to act outweighed these other factors, the Director has effectively established a new basis for discretionary denial under Section 314(a) to add the existing list.”The recent decision in iRhythm Technologies v. Welch Allyn Inc., IPR2025-00377, et al.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →